Radiofrequency ablation of Barrett's esophagus

G. Arora, S. Basra, A. K. Roorda, George Triadafilopoulos

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: Barrett's esophagus (BE) is an important risk factor for esophageal carcinoma and its incidence is likely rising. Amongst the various available endoscopic ablative therapies, radiofrequency ablation (RFA) is a very promising new one. Methods: We performed a comprehensive review of the literature on the treatment of BE using RFA. We searched for published articles on Pubmed and also reviewed the abstracts from the major gastroenterological society meetings of 2007 and 2008. Results: RFA is an effective option in treating BE, especially when dysplastic changes are present, achieving high eradication rates with minimal complications. Prior control of intra-esophageal pH by either armacologic therapy or fundoplication is important in maximizing ef-ficacy and preventing relapse. Conclusions: RFA is a very well tolerated therapy for non-dysplastic and dysplastic BE and will likely become a first-line treatment.More data, however, will be needed to compare the various existing modalities of endoscopic ablative and resection therapies for BE.

Original languageEnglish (US)
Pages (from-to)19-25
Number of pages7
JournalEuropean Surgery - Acta Chirurgica Austriaca
Volume41
Issue number1
DOIs
StatePublished - 2009

Fingerprint

Barrett Esophagus
Fundoplication
Therapeutics
PubMed
Carcinoma
Recurrence
Incidence

Keywords

  • Ablation
  • Barrett's
  • Radiofrequency

ASJC Scopus subject areas

  • Surgery

Cite this

Radiofrequency ablation of Barrett's esophagus. / Arora, G.; Basra, S.; Roorda, A. K.; Triadafilopoulos, George.

In: European Surgery - Acta Chirurgica Austriaca, Vol. 41, No. 1, 2009, p. 19-25.

Research output: Contribution to journalArticle

Arora, G, Basra, S, Roorda, AK & Triadafilopoulos, G 2009, 'Radiofrequency ablation of Barrett's esophagus', European Surgery - Acta Chirurgica Austriaca, vol. 41, no. 1, pp. 19-25. https://doi.org/10.1007/s10353-009-0447-z
Arora, G. ; Basra, S. ; Roorda, A. K. ; Triadafilopoulos, George. / Radiofrequency ablation of Barrett's esophagus. In: European Surgery - Acta Chirurgica Austriaca. 2009 ; Vol. 41, No. 1. pp. 19-25.
@article{8d2871e8c4604e4dabf5a68d8b973b24,
title = "Radiofrequency ablation of Barrett's esophagus",
abstract = "Background: Barrett's esophagus (BE) is an important risk factor for esophageal carcinoma and its incidence is likely rising. Amongst the various available endoscopic ablative therapies, radiofrequency ablation (RFA) is a very promising new one. Methods: We performed a comprehensive review of the literature on the treatment of BE using RFA. We searched for published articles on Pubmed and also reviewed the abstracts from the major gastroenterological society meetings of 2007 and 2008. Results: RFA is an effective option in treating BE, especially when dysplastic changes are present, achieving high eradication rates with minimal complications. Prior control of intra-esophageal pH by either armacologic therapy or fundoplication is important in maximizing ef-ficacy and preventing relapse. Conclusions: RFA is a very well tolerated therapy for non-dysplastic and dysplastic BE and will likely become a first-line treatment.More data, however, will be needed to compare the various existing modalities of endoscopic ablative and resection therapies for BE.",
keywords = "Ablation, Barrett's, Radiofrequency",
author = "G. Arora and S. Basra and Roorda, {A. K.} and George Triadafilopoulos",
year = "2009",
doi = "10.1007/s10353-009-0447-z",
language = "English (US)",
volume = "41",
pages = "19--25",
journal = "Acta Chirurgica Austriaca",
issn = "0001-544X",
publisher = "Springer Wien",
number = "1",

}

TY - JOUR

T1 - Radiofrequency ablation of Barrett's esophagus

AU - Arora, G.

AU - Basra, S.

AU - Roorda, A. K.

AU - Triadafilopoulos, George

PY - 2009

Y1 - 2009

N2 - Background: Barrett's esophagus (BE) is an important risk factor for esophageal carcinoma and its incidence is likely rising. Amongst the various available endoscopic ablative therapies, radiofrequency ablation (RFA) is a very promising new one. Methods: We performed a comprehensive review of the literature on the treatment of BE using RFA. We searched for published articles on Pubmed and also reviewed the abstracts from the major gastroenterological society meetings of 2007 and 2008. Results: RFA is an effective option in treating BE, especially when dysplastic changes are present, achieving high eradication rates with minimal complications. Prior control of intra-esophageal pH by either armacologic therapy or fundoplication is important in maximizing ef-ficacy and preventing relapse. Conclusions: RFA is a very well tolerated therapy for non-dysplastic and dysplastic BE and will likely become a first-line treatment.More data, however, will be needed to compare the various existing modalities of endoscopic ablative and resection therapies for BE.

AB - Background: Barrett's esophagus (BE) is an important risk factor for esophageal carcinoma and its incidence is likely rising. Amongst the various available endoscopic ablative therapies, radiofrequency ablation (RFA) is a very promising new one. Methods: We performed a comprehensive review of the literature on the treatment of BE using RFA. We searched for published articles on Pubmed and also reviewed the abstracts from the major gastroenterological society meetings of 2007 and 2008. Results: RFA is an effective option in treating BE, especially when dysplastic changes are present, achieving high eradication rates with minimal complications. Prior control of intra-esophageal pH by either armacologic therapy or fundoplication is important in maximizing ef-ficacy and preventing relapse. Conclusions: RFA is a very well tolerated therapy for non-dysplastic and dysplastic BE and will likely become a first-line treatment.More data, however, will be needed to compare the various existing modalities of endoscopic ablative and resection therapies for BE.

KW - Ablation

KW - Barrett's

KW - Radiofrequency

UR - http://www.scopus.com/inward/record.url?scp=62249099945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62249099945&partnerID=8YFLogxK

U2 - 10.1007/s10353-009-0447-z

DO - 10.1007/s10353-009-0447-z

M3 - Article

VL - 41

SP - 19

EP - 25

JO - Acta Chirurgica Austriaca

JF - Acta Chirurgica Austriaca

SN - 0001-544X

IS - 1

ER -